Literature DB >> 11998885

Bone marrow transplantation retinopathy.

F Gómez-Ulla1, M J Rodríguez-Cid, M Gómez-Torreiro, D Abelenda.   

Abstract

BACKGROUND: Bone marrow transplantion (BMT) is the treatment of choice for both malignant and nonmalignant disorders of the bone marrow. BMT retinopathy occurs after a latent period of 6 months and usually recovers after a few weeks.
METHODS: We present a case of BMT retinopathy (BMT) in a patient with a high-degree of non-Hodgkin lymphoma. We analysed the funduscopic and angiographic findings, and the evolution of the case. RESULTS AND
CONCLUSIONS: After a period of two and a half years we observed the spontaneous complete resolution of the fundus lesions and the recovery of visual acuity All of this confirm the theory that BMT retinopathy does not progress beyond the ischemic microvascular stage.

Entities:  

Mesh:

Year:  2001        PMID: 11998885     DOI: 10.1023/a:1014436212791

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  4 in total

1.  Bone marrow transplant retinopathy.

Authors:  P F Lopez; P Sternberg; C K Dabbs; W R Vogler; I Crocker; N S Kalin
Journal:  Am J Ophthalmol       Date:  1991-12-15       Impact factor: 5.258

2.  The eye in bone marrow transplantation. I. Clinical study.

Authors:  L W Hirst; D A Jabs; P J Tutschka; W R Green; G W Santos
Journal:  Arch Ophthalmol       Date:  1983-04

3.  Microvasculopathy in the ocular fundus after bone marrow transplantation.

Authors:  W Bernauer; A Gratwohl; A Keller; B Daicker
Journal:  Ann Intern Med       Date:  1991-12-15       Impact factor: 25.391

4.  The eye in bone marrow transplantation. VI. Retinal complications.

Authors:  N M Coskuncan; D A Jabs; J P Dunn; J A Haller; W R Green; G B Vogelsang; G W Santos
Journal:  Arch Ophthalmol       Date:  1994-03
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.